- PR Newswire•7 days ago
EPALINGES, Switzerland, Dec. 1, 2016 /PRNewswire/ -- Mymetics Corporation (MYMX), a pioneer and leader in the research and development of virosome-based vaccines to prevent transmission of human infectious diseases, announced today that its subsidiary Mymetics B.V. has agreed on a research project with Sanofi Pasteur, the vaccine division of Sanofi (SNY). The project will investigate the immunogenicity of influenza vaccines based on Mymetics' proprietary virosome technology platform in pre-clinical settings. "We are very excited to start this initial collaboration project with Sanofi, a world leader in the vaccine industry," said Ronald Kempers, CEO of Mymetics.
- Capital Cube•21 days ago
Categories: Yahoo Finance Get free summary analysis Mymetics Corp. reports financial results for the quarter ended September 30, 2016. We analyze the earnings along side the following peers of Mymetics Corp. – Vical Incorporated, Novartis AG Sponsored ADR and ADMA Biologics, Inc. (VICL-US, NVS-US and ADMA-US) that have also reported for this period. Highlights Summary numbers: Revenues of ... Read more (Read more...)
- PR Newswire•3 months ago
EPALINGES, Switzerland, Sept. 19, 2016 /PRNewswire/ -- Mymetics Corporation (MYMX), a pioneer in the research and development of virosome-based vaccines to prevent transmission of human infectious agents across mucosal membranes, announced today the continuation of the collaboration with the Texas Biomedical Research Institute related to the Mymetics' HIV vaccine candidate. In April this year, both organizations announced the results from a non-human primate study which was led by Dr. Ruth Ruprecht, Scientist & Director of the Texas Biomed AIDS Research Program and funded by the Bill & Melinda Gates Foundation, where Mymetics' two-component virosome-based HIV vaccine was able to show significant efficacy of 87% in delaying the time to persistent infection versus the control group after seven intravaginal virus challenges.
MYMX : Summary for MYMETICS CORP COM USD0.01 - Yahoo Finance
Mymetics Corporation (MYMX)
Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
|Day's Range||0.01 - 0.02|
|52 Week Range||0.01 - 0.08|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-1.32|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|